Analytical Data
-
Gene name
DA
- Application
-
Alternative Names
DA；DAT1；Sodium-dependent dopamine transporter
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8TAP4
-
Expression Region
1-145aa
-
AA Sequence
MLSVQPDTKP KGCAGCNRKI KDRYLLKALD KYWHEDCLKC ACCDCRLGEV GSTLYTKANL ILCRRDYLRL FGVTGNCAAC SKLIPAFEMV MRAKDNVYHL DCFACQLCNQ RFCVGDKFFL KNNMILCQTD YEEGLMKEGY APQVR
-
Molecular Weight
16.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
DA (Dipeptidyl Aminopeptidase) recombinant proteins have garnered significant attention in the field of biotechnology and biomedicine due to their crucial role in various physiological processes and disease mechanisms. Dipeptidyl aminopeptidases, particularly DPP-IV (Dipeptidyl Peptidase IV), are enzymes that regulate the activity of important hormones, including incretins that modulate glucose homeostasis, making them vital in the context of diabetes and metabolic syndrome. Moreover, DA proteins have been implicated in immune response modulation and have been explored as potential therapeutic targets in cancer and autoimmune diseases. The advances in recombinant DNA technology have enabled the production of these proteins in a controlled environment, enhancing their availability for research and therapeutic applications. This has led to the development of various inhibitors, which are utilized in the management of type 2 diabetes and other metabolic disorders. With ongoing research into their structural-functional relationships and therapeutic potentials, the study of DA recombinant proteins continues to pave the way for novel treatment strategies and the broader understanding of their biological significance in health and disease.
